BUSINESS

ASK THE EXPERTS

How can I design an effective combination treatment plan?

DR PARIS ACHARYA

Dr Paris Acharya (BDS Hons, MBChB, MFDS, MRCS Ed) is the Founder & Medical Director of Clinic Dr Paris in London. A dual-qualified doctor and dentist with a background in maxillofacial surgery, she specialises in regenerative aesthetics, skin health and longevity medicine. Known for her subtle, precision-led approach, Dr Paris focuses on natural, undetectable results through personalised, consultation-driven treatment plans.

Aesthetic medicine is moving decisively away from single-modality treatments toward integrated, combination-led approaches. This isn’t a trend, it’s a reflection of a deeper, more accurate understanding of how our face and skin ages, and what it takes to address that meaningfully.

I strongly advocate for an integrative approach that combines treatments. Skin ageing is not a single-layer problem. It involves collagen depletion, elastin fragmentation, impaired cellular signalling, vascular changes, and chronic low-grade inflammation occurring simultaneously, across multiple tissue depths. No single treatment addresses all of this. A useful way to think about it: muscle stimulation supports the underlying tissue, providing the structural pillow beneath the skin; radiofrequency works to smooth and tighten the surface above. Each does something distinct. Together, they do something neither could achieve alone.

By combining treatments thoughtfully, we can target multiple pathways simultaneously, enhance overall efficacy, extend the longevity of results, and reduce the need for more aggressive interventions over time. This is the philosophy underpinning regenerative and preventative aesthetics and it’s where the most sophisticated clinical practice now sits.

Effective combination protocols are designed with intention.

Start with a consultation-led approach: understand the patient’s skin biology, lifestyle, and expectations before designing a protocol. Sequence treatments appropriately, regenerative treatments generally precede structural ones. Avoid overloading the skin; more treatments do not mean better outcomes. And invest time in educating patients on the rationale behind combination approaches. Understanding builds trust.

I encourage clinicians to think in layers. The sequence matters. Each layer creates the conditions for the next to perform better.

Preparation remains one of the most underestimated aspects of combination treatment. Without this foundation, outcomes are consistently compromised. Skin that is inflamed, barrier-impaired, or sensitised will not respond optimally to injectables or devices. The skin must be ready to receive treatment, not just subjected to it. Addressing this first through barrier repair protocols, topical regenerative formulations, LED therapy, or simplified skincare can significantly improve the outcome of everything that follows.

From there, regenerative stimulation: peptide mesotherapy, polynucleotides, or biostimulators such as calcium hydroxylapatite work to restore cellular function and improve tissue quality at depth.

Structural support follows where appropriate - hyaluronic acid fillers or collagen-stimulating injectables to restore volume and integrity. Next, muscle lifting technologies can improve tone and support soft tissue positioning in ways that complement injectable work beautifully. Finally, the clinic can target surface refinement by addressing texture and tone.

When treatments are combined thoughtfully, the outcome is greater than the sum of its parts. Improving skin quality with for instance, directly enhances how the skin responds to both injectables and devices. The biology improves, and so does everything built on top of it.

Patients are also increasingly seeking natural, undetectable results. Subtle improvements across multiple parameters rather than a single visible change. Combination approaches deliver exactly this.

I often speak about yield preservation: protecting and extending the benefit of each intervention rather than repeatedly starting from scratch. When you support the skin’s underlying biology, results last longer. And by working with smaller, more strategic inputs, clinicians can achieve refined outcomes without relying on high volumes or aggressive techniques.

Systems such as CACI Rejuva Med plays a meaningful role within combination protocols, particularly as it offers five technologies in one, addressing skin preparation, RF, microcurrent muscle toning and lifting, FPL skin rejuvenation and PDRN Infusion, and are especially valuable for patients seeking non-surgical treatments with minimal downtime.

Combination treatments represent a more sophisticated, biologically aligned approach to aesthetic medicine. Rather than chasing isolated outcomes, we can now restore, support, and optimise the skin as a living system. This shift not only improves results, but it also elevates the standard of care. It moves the industry toward something more thoughtful, more regenerative, and more patient centred. That, to me, is where aesthetic medicine belongs..